New Risk • Jun 22
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: RM41.5m (US$10.00m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 16% per year over the past 5 years. Market cap is less than US$10m (RM41.5m market cap, or US$10.00m). Reported Earnings • May 31
Full year 2026 earnings released: RM0.014 loss per share (vs RM0.037 loss in FY 2025) Full year 2026 results: RM0.014 loss per share (improved from RM0.037 loss in FY 2025). Revenue: RM195.0m (up 6.2% from FY 2025). Net loss: RM3.32m (loss narrowed 63% from FY 2025). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings. Reported Earnings • Feb 26
Third quarter 2026 earnings released: RM0.001 loss per share (vs RM0.008 profit in 3Q 2025) Third quarter 2026 results: RM0.001 loss per share (down from RM0.008 profit in 3Q 2025). Revenue: RM51.9m (up 7.8% from 3Q 2025). Net loss: RM135.0k (down 107% from profit in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings. 공시 • Jan 02
Esthetics International Group Berhad Announces Redesignation of Cik Janet Chieng Ling Min from Executive Director to Non Executive Director, Effective January 1, 2026 Esthetics International Group Berhad has announced the redesignation of Cik Janet Chieng Ling Min from Executive Director to Non Executive Director, effective January 1, 2026. Cik Janet Chieng Ling Min, aged 34, holds a degree in Commerce and Law from the University of New South Wales, Australia. Ms. Janet Chieng joined Esthetics International Group Berhad as a Business Development Director in July 2015. Prior to joining, she had over two years experience in equity research focusing on companies in the Australian retail sector with Citigroup in Sydney, Australia. Directorate: Non Independent and Non Executive. Board Change • Dec 04
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Chze Poh was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 28
Second quarter 2026 earnings released: RM0.007 loss per share (vs RM0.023 loss in 2Q 2025) Second quarter 2026 results: RM0.007 loss per share (improved from RM0.023 loss in 2Q 2025). Revenue: RM45.5m (up 2.4% from 2Q 2025). Net loss: RM1.79m (loss narrowed 68% from 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. Reported Earnings • Sep 02
First quarter 2026 earnings released: EPS: RM0 (vs RM0.004 loss in 1Q 2025) First quarter 2026 results: EPS: RM0 (improved from RM0.004 loss in 1Q 2025). Revenue: RM50.4m (up 10% from 1Q 2025). Net income: RM70.0k (up RM1.06m from 1Q 2025). Profit margin: 0.1% (up from net loss in 1Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings. Board Change • Sep 02
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Senior Independent Non-Executive Director Boon Chiang Boh was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Aug 06
Full year 2025 earnings released: RM0.037 loss per share (vs RM0.007 loss in FY 2024) Full year 2025 results: RM0.037 loss per share (further deteriorated from RM0.007 loss in FY 2024). Revenue: RM183.6m (up 2.4% from FY 2024). Net loss: RM8.86m (loss widened 471% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings. 공시 • Jul 31
Esthetics International Group Berhad, Annual General Meeting, Sep 25, 2025 Esthetics International Group Berhad, Annual General Meeting, Sep 25, 2025, at 14:30 Singapore Standard Time. Location: auditorium, lot 11, jalan astaka u8/88, bukit jelutong, seksyen u8, 40150 shah alam, selangor darul ehsan, Malaysia Board Change • Jun 19
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Senior Independent Non-Executive Director Boon Chiang Boh was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • May 30
Full year 2025 earnings released: RM0.038 loss per share (vs RM0.007 loss in FY 2024) Full year 2025 results: RM0.038 loss per share (further deteriorated from RM0.007 loss in FY 2024). Revenue: RM183.6m (up 2.4% from FY 2024). Net loss: RM8.92m (loss widened 475% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. Board Change • May 27
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Senior Independent Non-Executive Director Boon Chiang Boh was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Feb 23
Third quarter 2025 earnings released: EPS: RM0.008 (vs RM0 in 3Q 2024) Third quarter 2025 results: EPS: RM0.008 (up from RM0 in 3Q 2024). Revenue: RM48.1m (up 5.6% from 3Q 2024). Net income: RM1.87m (up RM1.84m from 3Q 2024). Profit margin: 3.9% (up from 0.1% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 11% per year whereas the company’s share price has fallen by 13% per year. Board Change • Feb 03
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Senior Independent Non-Executive Director Boon Chiang Boh was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Jan 02
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 3 experienced directors. 3 highly experienced directors. 3 independent directors (4 non-independent directors). Senior Independent Non-Executive Director Boon Chiang Boh was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Nov 28
Second quarter 2025 earnings released: RM0.023 loss per share (vs RM0.003 profit in 2Q 2024) Second quarter 2025 results: RM0.023 loss per share (down from RM0.003 profit in 2Q 2024). Revenue: RM44.4m (down 4.8% from 2Q 2024). Net loss: RM5.51m (down RM6.17m from profit in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Declared Dividend • Oct 09
Dividend of RM0.005 announced Shareholders will receive a dividend of RM0.005. Ex-date: 18th October 2024 Payment date: 20th November 2024 Dividend yield will be 1.7%, which is lower than the industry average of 3.0%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (8% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. 공시 • Oct 07
Esthetics International Group Berhad Announces Final Single-Tier Dividend for the Financial Year Ended 31 March 2024, Payable on 20 November 2024 Esthetics International Group Berhad announced Final Single-Tier Dividend of 0.50 sen per ordinary share for the financial year ended 31 March 2024. Payment Date: 20 November 2024. Ex-Date: 18 October 2024. Entitlement date: 21 October 2024. 공시 • Sep 12
Esthetics International Group Berhad Appoints Choo Kim Wong as Chief Financial Officer Esthetics International Group Berhad announced the appointment of Mr. Choo Kim Wong as chief financial officer. Date of change is 11 September 2024. Age: 47. Qualifications: Professional Qualification, Accountancy, The Association of Chartered Certified Accountants (ACCA), Fellow Chartered and Certified Accountant (FCCA); Diploma, Business Administration, The Association of Business Executives, United Kingdom, Diploma of Business Admin. Working experience and occupation: Mr. Choo Kim Wong (Eric) was previously the Chief Financial Officer of Healthcare Planet Sdn Bhd from January 2021 to August 2024 and Director of Finance of Thai Odyssey Sdn Bhd from February 2013 to October 2020. Prior to this, Eric had over 7 years experience with Esthetics International Group Bhd (the Company), with his last position as Group Financial Controller of EIG, as well as experience with Inti Universal Holdings Berhad and Deloitte Malaysia. 공시 • Sep 11
Esthetics International Group Berhad Announces Resignation of Miss Chen Yoke Heng as Chief Financial Officer Esthetics International Group Berhad announced resignation of Miss Chen Yoke Heng as chief financial officer of the company. Date of change is 11 September 2024. Age: 53. Reason: To pursue other career objectives. Qualifications: Degree, Bachelor of Arts majoring in Accounting (Second Class Honours, First Division), University of Bolton, UK; Diploma, Higher Diploma in Accounting, Association of Accounting Technicians, UK. Working experience and occupation: Ms. Chen Yoke Heng has over 30 years experience in finance and accounting with several public companies within the retail, consumer goods and manufacturing sectors and was the Group CFO of the Company for 7 years. 공시 • Aug 30
Esthetics International Group Berhad Announces Redesignation of Noor Zalmy Azizan Binti Mohd Ali Azizan to Non-Independent Director Esthetics International Group Berhad announced redesignation of Dato' Dr. Noor Zalmy Azizan Binti Mohd Ali Azizan, from the previous position of Independent Director to the new position of Non-Independent Director. Age is 56 years. Directorate is Non Independent and Non Executive. Date of change is 30 August 2024. Reported Earnings • Aug 06
Full year 2024 earnings released: RM0.007 loss per share (vs RM0.024 loss in FY 2023) Full year 2024 results: RM0.007 loss per share (improved from RM0.024 loss in FY 2023). Revenue: RM179.3m (up 8.6% from FY 2023). Net loss: RM1.55m (loss narrowed 73% from FY 2023). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. 공시 • Jul 30
Esthetics International Group Berhad, Annual General Meeting, Sep 26, 2024 Esthetics International Group Berhad, Annual General Meeting, Sep 26, 2024, at 14:30 Singapore Standard Time. Location: auditorium, lot 11, jalan astaka u8/88, bukit jelutong, seksyen u8, 40150 shah alam, selangor darul ehsan, Malaysia Reported Earnings • Jun 05
Full year 2024 earnings released: RM0.007 loss per share (vs RM0.024 loss in FY 2023) Full year 2024 results: RM0.007 loss per share (improved from RM0.024 loss in FY 2023). Revenue: RM179.3m (up 8.6% from FY 2023). Net loss: RM1.62m (loss narrowed 72% from FY 2023). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Reported Earnings • Feb 28
Third quarter 2024 earnings released: EPS: RM0 (vs RM0.009 loss in 3Q 2023) Third quarter 2024 results: EPS: RM0 (improved from RM0.009 loss in 3Q 2023). Revenue: RM45.6m (up 6.5% from 3Q 2023). Net income: RM25.0k (up RM2.22m from 3Q 2023). Profit margin: 0.1% (up from net loss in 3Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 7% per year. Buy Or Sell Opportunity • Feb 26
Now 20% overvalued The stock has been flat over the last 90 days, currently trading at RM0.32. The fair value is estimated to be RM0.27, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Nov 30
Second quarter 2024 earnings released: EPS: RM0.003 (vs RM0.003 loss in 2Q 2023) Second quarter 2024 results: EPS: RM0.003 (up from RM0.003 loss in 2Q 2023). Revenue: RM46.7m (up 15% from 2Q 2023). Net income: RM660.0k (up RM1.32m from 2Q 2023). Profit margin: 1.4% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Board Change • Nov 14
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Senior Independent Non-Executive Director Boon Chiang Boh was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Sep 22
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Senior Independent Non-Executive Director Boon Chiang Boh was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 25
First quarter 2024 earnings released: EPS: RM0 (vs RM0.008 loss in 1Q 2023) First quarter 2024 results: EPS: RM0 (improved from RM0.008 loss in 1Q 2023). Revenue: RM42.3m (up 19% from 1Q 2023). Net income: RM106.0k (up RM2.09m from 1Q 2023). Profit margin: 0.3% (up from net loss in 1Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. Board Change • Aug 08
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Senior Independent Non-Executive Director Boon Chiang Boh was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. 공시 • Jul 29
Esthetics International Group Berhad, Annual General Meeting, Sep 27, 2023 Esthetics International Group Berhad, Annual General Meeting, Sep 27, 2023, at 10:00 Singapore Standard Time. Location: Auditorium, Lot 11, Jalan Astaka U8/88, Bukit Jelutong, Seksyen U8, Darul Ehsan Shah Alam Selangor Malaysia Agenda: To receive the Audited Financial Statements for the financial year ended 31 March 2023 together with the Directors and Auditors Reports thereon; To approve the payment of a final single-tier dividend of 0.5 sen per ordinary share in respect of the financial year ended 31 March 2023; To re-elect Mr. Chieng Ing Huong who is retiring pursuant to Article 103 of the Company's Constitution; and to discuss other matters. Board Change • Jul 11
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Senior Independent Non-Executive Director Boon Chiang Boh was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. 공시 • Jun 08
Esthetics International Group Berhad Announces Appointment of Tan Kok Aun as Company Secretary Esthetics International Group Berhad announced appointment of Tan Kok Aun as Company Secretary. Date Of Change is 07 June 2023. Reported Earnings • Jun 01
Full year 2023 earnings released: RM0.024 loss per share (vs RM0.026 loss in FY 2022) Full year 2023 results: RM0.024 loss per share (improved from RM0.026 loss in FY 2022). Revenue: RM165.1m (up 33% from FY 2022). Net loss: RM5.68m (loss narrowed 7.4% from FY 2022). Board Change • May 03
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Senior Independent Non-Executive Director Christopher Chan was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Mar 01
Third quarter 2023 earnings released: RM0.009 loss per share (vs RM0.011 profit in 3Q 2022) Third quarter 2023 results: RM0.009 loss per share (down from RM0.011 profit in 3Q 2022). Revenue: RM42.8m (up 7.1% from 3Q 2022). Net loss: RM2.19m (down 186% from profit in 3Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance. Reported Earnings • Nov 25
Second quarter 2023 earnings released: RM0.003 loss per share (vs RM0.018 loss in 2Q 2022) Second quarter 2023 results: RM0.003 loss per share (improved from RM0.018 loss in 2Q 2022). Revenue: RM40.5m (up 86% from 2Q 2022). Net loss: RM662.0k (loss narrowed 84% from 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance. Board Change • Nov 16
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Senior Independent Non-Executive Director Christopher Chan was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Oct 27
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Senior Independent Non-Executive Director Christopher Chan was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. 공시 • Oct 04
Esthetics International Group Berhad Announces Final Single-Tier Dividend for the Financial Year Ended 31 March 2022, Payable on November 18, 2022 Esthetics International Group Berhad announced final single-tier dividend of 0.50 sen per ordinary share for the financial year ended 31 March 2022. Ex-date is October 18, 2022. Entitlement date is October 19, 2022. Payment date is November 18, 2022. Reported Earnings • Aug 04
Full year 2022 earnings released: RM0.026 loss per share (vs RM0.009 profit in FY 2021) Full year 2022 results: RM0.026 loss per share (down from RM0.009 profit in FY 2021). Revenue: RM124.6m (down 3.8% from FY 2021). Net loss: RM6.13m (down 396% from profit in FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 97 percentage points per year, which is a significant difference in performance. 공시 • Jul 30
Esthetics International Group Berhad, Annual General Meeting, Sep 28, 2022 Esthetics International Group Berhad, Annual General Meeting, Sep 28, 2022, at 14:30 Singapore Standard Time. Agenda: To receive the Audited Financial Statements for the financial year ended 31 March 2022 together with the Directors and Auditors Reports thereon; to approve the payment of final single-tier dividend of 0.5 sen per ordinary share in respect of the financial year ended 31 March 2022; to re-appoint Messrs Baker Tilly Monteiro Heng PLT as Auditors of the Company for the ensuing year and to authorize the Directors to fix remuneration; and to consider any other business that can be transacted in an annual general meeting of which due notice shall have been received. Board Change • Jun 16
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Senior Independent Non-Executive Director Christopher Chan was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Jun 03
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2022 results: RM0.026 loss per share (down from RM0.009 profit in FY 2021). Revenue: RM124.6m (down 3.8% from FY 2021). Net loss: RM6.13m (down 396% from profit in FY 2021). Revenue exceeded analyst estimates by 5.6%. Earnings per share (EPS) missed analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 102 percentage points per year, which is a significant difference in performance. Buying Opportunity • May 18
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 14%. The fair value is estimated to be RM0.43, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Meanwhile, the company became loss making. Board Change • Apr 27
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Senior Independent Non-Executive Director Christopher Chan was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Mar 03
Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Third quarter 2022 results: EPS: RM0.011 (up from RM0.004 in 3Q 2021). Revenue: RM40.0m (up 3.3% from 3Q 2021). Net income: RM2.55m (up 159% from 3Q 2021). Profit margin: 6.4% (up from 2.5% in 3Q 2021). Revenue exceeded analyst estimates by 5.6%. Earnings per share (EPS) missed analyst estimates by 4.2%. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance. Board Change • Jan 02
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Senior Independent Non-Executive Director Christopher Chan was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 26
Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Second quarter 2022 results: RM0.018 loss per share (down from RM0.006 profit in 2Q 2021). Revenue: RM21.8m (down 41% from 2Q 2021). Net loss: RM4.24m (down 379% from profit in 2Q 2021). Revenue exceeded analyst estimates by 5.6%. Earnings per share (EPS) missed analyst estimates. Earnings per share (EPS) missed analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance. Reported Earnings • Sep 28
First quarter 2022 earnings released: RM0.025 loss per share (vs RM0.008 loss in 1Q 2021) The company reported a soft first quarter result with increased losses and weaker control over costs, although revenues improved. First quarter 2022 results: Revenue: RM25.8m (up 16% from 1Q 2021). Net loss: RM5.94m (loss widened 218% from 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings. Reported Earnings • May 29
Full year 2021 earnings released: EPS RM0.009 (vs RM0.022 in FY 2020) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2021 results: Revenue: RM129.5m (down 24% from FY 2020). Net income: RM2.07m (down 60% from FY 2020). Profit margin: 1.6% (down from 3.0% in FY 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Reported Earnings • Feb 26
Third quarter 2021 earnings released: EPS RM0.004 (vs RM0.009 in 3Q 2020) The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: RM38.7m (down 21% from 3Q 2020). Net income: RM984.0k (down 53% from 3Q 2020). Profit margin: 2.5% (down from 4.2% in 3Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 16% per year whereas the company’s share price has fallen by 13% per year. Is New 90 Day High Low • Feb 02
New 90-day low: RM0.39 The company is down 7.0% from its price of RM0.42 on 03 November 2020. The Malaysian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Services industry, which is up 26% over the same period. 